Elizabeth Mccready

Hamilton, ON L8S4K1, Canada

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 29 publications

Optimized Test Utilization Significantly Increased the Positive Detection Rate for Myeloproliferative Neoplasms.

Optimized Test Utilization Significantly Increased the Positive Detection Rate for Myeloproliferative Neoplasms.

Journal: Cancers

Published: June 11, 2026

Transforming blood-derived episignatures into cell-type-agnostic classifiers: A shortcut to prenatal episignatures.

Transforming blood-derived episignatures into cell-type-agnostic classifiers: A shortcut to prenatal episignatures.

Journal: American journal of human genetics

Published: January 07, 2026

Genetic modifiers and ascertainment drive variable expressivity of complex disorders.

Genetic modifiers and ascertainment drive variable expressivity of complex disorders.

Journal: medRxiv : the preprint server for health sciences

Published: September 10, 2024

Duplication of chromosome 1q32.1q44: presented with ventriculomegaly and transient myeloproliferative disorder of the newborn.

Duplication of chromosome 1q32.1q44: presented with ventriculomegaly and transient myeloproliferative disorder of the newborn.

Journal: Case reports in perinatal medicine

Published: August 20, 2024

Genetic modifiers and ascertainment drive variable expressivity of complex disorders.

Genetic modifiers and ascertainment drive variable expressivity of complex disorders.

Journal: Cell

Published: August 19, 2024

Early Mixed Donor Chimerism is a Strong Negative Prognostic Indicator in Allogeneic Stem Cell Transplant for AML and MDS.

Early Mixed Donor Chimerism is a Strong Negative Prognostic Indicator in Allogeneic Stem Cell Transplant for AML and MDS.

Journal: Transplantation and cellular therapy

Published: July 18, 2024

Concurrent BCR-ABL1 and core binding factor beta rearrangement in de novo acute myeloid leukemia: A case report and review of literature.

Concurrent BCR-ABL1 and core binding factor beta rearrangement in de novo acute myeloid leukemia: A case report and review of literature.

Journal: EJHaem

Published: January 14, 2024

Genetic and metabolic investigations for neurodevelopmental disorders: position statement of the Canadian College of Medical Geneticists (CCMG).

Genetic and metabolic investigations for neurodevelopmental disorders: position statement of the Canadian College of Medical Geneticists (CCMG).

Journal: Journal of medical genetics

Published: September 26, 2022

Evaluation of DNA Methylation Array for Glioma Tumor Profiling and Description of a Novel Epi-Signature to Distinguish IDH1/IDH2 Mutant and Wild-Type Tumors.

Evaluation of DNA Methylation Array for Glioma Tumor Profiling and Description of a Novel Epi-Signature to Distinguish IDH1/IDH2 Mutant and Wild-Type Tumors.

Journal: Genes

Published: September 12, 2022

Further characterization of the 9q31 microdeletion phenotype; delineation of a common region of overlap containing ZNF462.

Further characterization of the 9q31 microdeletion phenotype; delineation of a common region of overlap containing ZNF462.

Journal: Molecular genetics & genomic medicine

Published: June 10, 2022

Impaired OTUD7A-dependent Ankyrin regulation mediates neuronal dysfunction in mouse and human models of the 15q13.3 microdeletion syndrome.

Impaired OTUD7A-dependent Ankyrin regulation mediates neuronal dysfunction in mouse and human models of the 15q13.3 microdeletion syndrome.

Journal: Molecular psychiatry

Published: January 07, 2022

Practice guidelines for BRCA1/2 tumour testing in ovarian cancer.

Practice guidelines for BRCA1/2 tumour testing in ovarian cancer.

Journal: Journal of medical genetics

Published: September 23, 2021

Showing 1-12 of 29

Last Updated: 09/26/2026